ASD guideline supplementary paper: pharmacological interventions
Mental health and behavioural conditions
Clinical Settings: Disability, Community, Primary, Secondary
Resource type: Evidence-based guideline
Author: NZGG
Published: March 2011
Copyright Holder: Ministry of Health
This is a paper the provides supplementary evidence and recommendations to do with the pharmacological interventions: melatonin, aripiprazole and citalopram. The paper should be read as part of the New Zealand Autism Spectrum Disorder Guideline (2008).
Tags: ASD, autism spectrum disorder, melatonin, aripiprazole, citalopram, atypical antipsychotic, selective serotonin reuptake inhibitor, SSRI, hormone supplement